Updated Jul 16, 2026
Karp Daniel is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Daniel Karp is an executive known for his role as Executive Vice President of Corporate Development at Organon & Co., a global healthcare company focused on women's health and other critical health issues. He has extensive experience in corporate strategy and development within the pharmaceutical and healthcare sectors.
| Role | Executive VP, Corp. Dev. |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-02 | OGN | Organon & Co. | F — Tax withholding / forfeiture | 2.1K | $5.70 | $12K |
| 2026-04-02 | OGN | Organon & Co. | M — Option exercise | 6.7K | $0.00 | |
| 2026-04-02 | OGN | Organon & Co. | F — Tax withholding / forfeiture | 3.6K | $5.70 | $20K |
| 2026-04-02 | OGN | Organon & Co. | M — Option exercise | 11.3K | $0.00 | |
| 2026-03-31 | OGN | Organon & Co. | F — Tax withholding / forfeiture | 4.4K | $5.84 | $26K |
| 2026-03-31 | OGN | Organon & Co. | M — Option exercise | 14.2K | $0.00 |
Daniel Karp is an executive known for his role as Executive Vice President of Corporate Development at Organon & Co., a global healthcare company focused on women's health and other critical health issues. He has extensive experience in corporate strategy and development within the pharmaceutical and healthcare sectors.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Karp Daniel profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.